Literature DB >> 4114505

Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome.

J J Brown, R Fraser, D R Love, J B Ferriss, A F Lever, J I Robertson, A Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114505     DOI： 10.1016/s0140-6736(72)91685-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

3.  Excess deoxycorticosterone secretion from adrenocortical carcinoma.

Authors:  J D Powell-Jackson; A Calin; R Fraser; R Grahame; P Mason; G A Missen; P R Powell-Jackson; A Wilson
Journal:  Br Med J       Date:  1974-04-06

4.  Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment.

Authors:  R Pedrinelli; A Lucarini; L Graziadei; S Taddei; A Salvetti
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

5.  Rectal potential difference in the diagnosis of aldosterone excess.

Authors:  D G Beevers; J J Morton; M Tree; J Young
Journal:  Gut       Date:  1975-01       Impact factor: 23.059

6.  Periodic hypokalaemic paralysis, adrenal adenoma, and normal colonic transport of sodium and potassium.

Authors:  P Richards; M B Jones; W S Peart
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

7.  Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.

Authors:  A A Taylor; J R Mitchell; F C Bartter; W R Snodgrass; R J McMurtry; J R Gill; R B Franklin
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.

Authors:  J D Baxter; M Schambelan; D T Matulich; B J Spindler; A A Taylor; F C Bartter
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.

Authors:  F Skrabal
Journal:  J R Soc Med       Date:  1979-04       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.